Standard BioTools Inc. (LAB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -46.6M | -1.2M | -22.2M | -20.67M | -30.28M | -14.06M | -27.87M | -39.05M | -62.48M | -14.06M | -11.41M | -9.33M |
| Operating CF Margin % | -220.36% | -37.15% | -113.55% | -94.97% | -74.23% | -30.09% | -61.97% | -173.62% | -137.19% | -49.88% | -44.99% | -33.72% |
| Operating CF Growth % | -53.87% | 91.49% | 20.33% | 47.07% | 51.53% | 0.01% | -144.21% | -318.59% | -636.31% | 26.69% | 53.63% | 68.89% |
| Net Income | 127.07M | 19.28M | -34.69M | -33.46M | -26.03M | -34.07M | -26.94M | -45.72M | -32.16M | -19.78M | -21M | -17.04M |
| Depreciation & Amortization | 1.41M | 0 | 5.59M | 3.99M | 4.17M | 3.95M | 3.86M | 3.86M | 5.19M | 3.91M | 3.99M | 3.63M |
| Stock-Based Compensation | 8.82M | 5.74M | 7.54M | 5.37M | 9.01M | 7.47M | 5.92M | 6.73M | 3.57M | 3.48M | 3.39M | 3.11M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.51M | 391K | 0 |
| Other Non-Cash Items | -183.9M | 4.71M | 532K | 3.45M | -1.83M | -84K | -21K | 107K | -28.62M | 14.45M | 131K | 1.66M |
| Working Capital Changes | 0 | -30.93M | -1.18M | -29K | -15.6M | 8.67M | -10.69M | -4.03M | -10.46M | -1.61M | 1.69M | -688K |
| Change in Receivables | 0 | 6.73M | -5.79M | 2.02M | -2.02M | 6.7M | -2.74M | 4.33M | 686K | -3.67M | -1.56M | -789K |
| Change in Inventory | 0 | -1.17M | -1.8M | 3.82M | -3.82M | 5.03M | -2.13M | -6.45M | -6.33M | -1.66M | -1.32M | -852K |
| Change in Payables | 0 | 653K | 0 | 0 | -578K | 0 | -2.19M | -410K | 0 | 2.1M | 1.29M | 0 |
| Cash from Investing | 191.09M | -10.68M | -6.68M | 27.5M | 14.63M | 25.73M | -30.88M | 50.26M | 318.07M | -13.12M | -49.93M | 40.13M |
| Capital Expenditures | -570K | -476K | -886K | -1.89M | -5.05M | -3.38M | -2.25M | -1.94M | -781K | -78K | -905K | -838K |
| CapEx % of Revenue | 2.7% | 14.77% | 4.53% | 8.67% | 12.39% | 7.24% | 5.01% | 8.61% | 1.71% | 0.28% | 3.57% | 3.03% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -1.39M | 0 | 0 | 280.03M | 13.04M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 363.22M | -5M | -5.79M | 29.39M | 0 | 30.49M | 0 | 0 | 38.82M | -13.04M | 0 | 40.96M |
| Cash from Financing | -40K | 620K | -112K | 108K | -46K | -54.52M | -2K | -28.36M | -19.73M | -1M | -1.16M | -2.08M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | -55M | 0 | 0 | -8.19M | -1.25M | -833K | 0 |
| Equity Issued (Net) | 0 | 746K | -112K | -200K | -46K | -45K | 0 | -29.44M | -11.07M | -174K | -399K | -2.41M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -112K | -200K | -46K | -45K | 0 | -29.44M | -11.07M | -174K | -399K | -2.41M |
| Other Financing | -40K | -126K | 0 | 308K | 0 | 525K | -2K | 1.08M | -473K | 421K | 68K | 326K |
| Net Change in Cash | 144.57M | -11.36M | -29.2M | 7.73M | -15.35M | -43.12M | -59.16M | -17.24M | 235.84M | -27.95M | -62.65M | 28.64M |
| Free Cash Flow | -47.17M | -1.67M | -23.09M | -22.55M | -35.34M | -17.44M | -30.12M | -40.99M | -63.26M | -14.14M | -12.32M | -10.17M |
| FCF Margin % | -223.05% | -51.92% | -118.09% | -103.64% | -86.62% | -37.33% | -66.99% | -182.23% | -138.9% | -50.16% | -48.56% | -36.75% |
| FCF Growth % | -33.48% | 90.41% | 23.36% | 44.97% | 44.14% | -23.35% | -144.57% | -303.14% | -566.21% | 29.08% | 52.4% | 67.12% |
| FCF per Share | -0.12 | -0.00 | -0.06 | -0.06 | -0.09 | -0.05 | -0.08 | -0.11 | -0.22 | -0.18 | -0.16 | -0.13 |
| FCF Conversion (FCF/Net Income) | -0.37x | -0.06x | 0.64x | 0.62x | 1.16x | 0.41x | 1.03x | 0.85x | 1.94x | 0.71x | 0.54x | 0.55x |
| Interest Paid | 0 | 0 | 5K | 6K | 4K | 1.44M | 4K | 1.45M | 190K | 1.65M | 252K | 1.69M |
| Taxes Paid | 0 | 0 | 0 | 0 | 201K | 0 | 60K | 107K | 0 | 172K | 117K | 0 |